This Week in Psychedelics - 2.11.22

Cannabis

  • South Carolina Medical Marijuana Legalization Bill Officially Approved In Senate, Heads For House Consideration (Marijuana Moment)

  • Maryland Lawmakers Introduce Adult-Use Cannabis Legalization Bill (High Times)

  • UK trial of medical cannabis and long covid to get underway this month (Cannabis Health News)

  • The Super Bowl won’t be lit: no cannabis ads allowed (The Verge)

  • Bill Introduced to Raise THC Limit in Hemp to One Percent (High Times)

  • Cannabis Store Co-owned By Top Virginia Senator Sells Mislabeled Products With Illegal THC Content, Media Investigation Finds (Marijuana Moment)

  • Study Shreds Cannabis ‘Amotivational Syndrome’ Theory (High Times)

  • Flower still king of US marijuana market, though supremacy waning (Marijuana Business Daily)

  • Oklahoma Becomes Marijuana Legalization Battleground Between Advocates, With Legal Challenges And A New Ballot Initiative (Marijuana Moment)

  • New York Cracks Down on Illegal Cannabis Businesses (High Times)

  • Missouri Supreme Court Unanimously Orders Medical Marijuana Applicant Disclosures (Marijuana Moment)

  • Pennsylvania Senate committee holds first-ever hearing on legalizing recreational marijuana (WGAL)

  • Police Seizure Of Marijuana Dispensary Cash Leads To Federal Litigation (Marijuana Moment)

  • Cannabis platform Leafly closes merger with SPAC, goes public on Nasdaq (Marijuana Business Daily)

  • The Eternal Pricing Struggle of UK Medical Cannabis Patients (TalkingDrugs)

  • Weedmaps Ad Satirizes Plight Of Broccoli Emoji As Marijuana Stand-In On Social Media (Marijuana Moment)

  • Young cannabis users at increased risk of repeat stroke (Medical News Today)

  • Federally Owned Utility Company Walks Back Threat To Block Electricity For Marijuana Businesses (Marijuana Moment)

  • Cali Vibes Rocks Long Beach, Allowing Cannabis (High Times)

  • How does cannabis use affect brain health? Caution advised, more research needed, experts say (ScienceDaily)

LSD

  • Microdose Psychedelics Presents a Molecular Masterclass: The LSD Conference (GlobeNewswire)

Magic Mushrooms

  • Psilocybin microdosing does not reduce symptoms of depression or anxiety, according to placebo-controlled study (PsyPost)

  • Lawmakers say no to bill legalizing psilocybin-assisted therapy in Maine (The Portland Press Herald)

  • Oregon proposes only using one type of mushroom for new psilocybin system, and no pills (OPB)

  • More States Follow Oregon’s Lead Toward Legal Psilocybin Therapy (Lucid News)

  • Usona Identifies Controlled Crystal Engineering Process for Large-Scale Synthesis of Psilocybin Polymorphs (Business Wire)

  • Maine CDC Director Opposes Bill to Legalize Therapeutic Psilocybin (Psychedelic Spotlight)

  • The Many Types of Psychedelic Mushrooms (Truffle Report)

  • Mazatec Shamanic Knowledge and Psilocybin Mushrooms (Chacruna)

MDMA

DMT

Ayahuasca

  • Creating Awareness on Sexual Abuse in Ayahuasca Communities: A Review of Chacruna’s Guidelines (Chacruna)

5-MeO-DMT

  • Scientists Create Cell-Based Psychedelic Toad Venom, a Potential 5-MeO-DMT “Bio-Factory” (Lucid News)

Mescaline

Iboga

  • Osoyoos Indian Band eyes cutting-edge drug treatment centre (Vancouver Sun)

Novel Psychoactive Substances

  • Cybin Announces Grant of U.S. Patent Covering its Proprietary Compound CYB004 (Deuterated DMT) for the Treatment of Anxiety Disorders (Psilocybin Alpha)

Nitrous Oxide

  • Another new weapon to beat Corona, first 'nasal spray' launched in India (News Track)

  • Nitrous Oxide Safe For Dental Procedures In Children With Sickle Cell Disease: Study (Medical Dialogues)

Ketamine

  • Ketamine effectively silences suicidal thoughts, especially in bipolar patients (Study Finds)

  • Researching Ketamine for Social Anxiety Disorder (Truffle Report)

  • Yale researcher receives grant to study effects of ketamine in individuals with epilepsy (Yale Daily News)

  • Trip Tunes: A Conversation with Producer Jon Hopkins About Making Music for Ketamine (DoubleBlind)

  • Ketamine Infusions in the Home May Facilitate Safe Treatment Access During the Pandemic (Pharmacy Times)

Miscellaneous

  • Can microdosing psychedelics boost mental health? Here’s what the evidence suggests. (National Geographic)

  • Utah House Overwhelmingly Approves Psychedelics Study Task Force Bill (Marijuana Moment)

  • Maryland Senate Bill Would Provide ‘Cost-Free Access’ To Psychedelics For Military Veterans (Marijuana Moment)

  • Psychedelics Offer New Route to Recovery from Eating Disorders (NEO.LIFE)

  • Are Psychedelics the Future of Pain Relief? (VICE)

  • Michigan Activists Submit Psychedelics Decriminalization Language (High Times)

  • DEA Faces Backlash Over Proposed Scheduling Of Five Psychedelic Compounds (Marijuana Moment)

  • Proposed Drug-Decrim Ballot Initiative All Set in Washington State (Filter)

  • Can Psychedelics Make People More Drawn to Conspiracy Theories? (Sam Woolfe)

  • Yes, Psychedelics Do Change Our Metaphysical Beliefs (DoubleBlind)

  • Panel Discusses Coalition Building to Unlock Therapeutic Effects of Psychedelics (The Yale School)

  • Legal Psychedelics: The U.S. Cities Where Psilocybin, LSD And Others Are Decriminalized (Healing Maps)

  • Canada’s Reforms on Psychedelics Are Slowly Taking Shape (Bloomberg)

  • Survey Shows 65% of Affected Americans Want Access to Psychedelic Treatments for Mental Health Conditions (Pharmacy Times)

  • New Polling by Mind Medicine Australia Reveals Over 60% of Australians Support Increased Access to Psychedelic Medicines (Mind Medicine Australia)

  • Big Pharma In Psychedelics: Inside Mindset Pharma’s Deal With Otsuka (Forbes)

  • Using Real-World Evidence to Accelerate Psychedelic Drug Development (Truffle Report)

  • Is city getting ‘high’ on hallucinating drugs? (The Hindu)

  • Drug Euphoria Is a Good Thing, Actually (Filter)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.